Who founded Panome Bio?

Panome Bio was founded by Edward Weinstein, Tom Cohen in 2022.

Who are Panome Bio's investors?

Panome Bio's investors include BioGenerator Ventures, Telegraph Hill Partners, Cultivation Capital.

How much funding has Panome Bio raised?

Panome Bio has disclosed $12M raised across 2 rounds.

Where is Panome Bio headquartered?

Panome Bio is headquartered in Saint Louis, US.

Panome Bio

Saint Louis, US · Founded 2022 · Delaware corporation · 26 employees on LinkedIn · 3 known investors

Find your way into Panome Bio

704 people in our graph share verified history with the Panome Bio team — schools, employers, funds. One of them is your warm intro.

Adam Valkinunlockedknows Edward Weinstein · together at Harvard University (overlapped)

×3knows the team · via University of Michigan

×6knows the team · via Harvard University

×2knows the team · via Merck

Panome Bio provides metabolomics, proteomics, and multi-omics integration workflows along with a computational platform that analyzes and integrates diverse biological data types. It serves life science and biotechnology researchers looking to identify biomarkers and generate research insights.

AI & Machine Learning Biotech Deep Tech Healthtech

Founders & leadership

Panome Bio was founded in 2022 by Edward Weinstein and Tom Cohen.

Edward Weinstein inCo-Founder and CEOEdward Weinstein has over 20 years of leadership experience in the life sciences sector, including roles in genetic engineering and personalized medicine, and currently leads Panome Bio as Executive Officer and Director.

Tom CoheninCo-Founder and President

Board

David Smoller inCo-Founder/Board MemberGeneral Partner at Cultivation Capital

Deval Lashkari inDirector Board of DirectorsSenior Partner at Telegraph Hill Partners

Alexander Herzick inBoard directorPartner at Telegraph Hill Partners

Rob Capone inBoard directorPartner at Telegraph Hill Partners

Investors · 3

BioGenerator VenturesSt. Louis · $50K – $250K

Telegraph Hill PartnersSan Francisco · $2M – $8M

Cultivation CapitalreportedSt. Louis · $100K – $3.5Mvia David Smoller · board

Reported raises · per SEC filings

Form D private placements

$12M disclosed across 2 rounds · 2023–2024

▶$6MraisedNov 2024 · 6 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

David SmollerDirector
Tom CohenExecutive Officer
Rob CaponeDirector
Edward WeinsteinExecutive Officer, Director
Deval LashkariDirector

Offering amount: $6M
Amount sold: $6M
Minimum investment: $25K
First sale: Nov 2024
Incorporated: Corporation, Delaware, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$6MraisedFeb 2023 · 6 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

David SmollerDirector
Deval LashkariDirector
Alexander HerzickDirector
Edward WeinsteinExecutive Officer, Director
Tom CohenExecutive Officer
Rob CaponeDirector

Offering amount: $6M
Amount sold: $6M
Minimum investment: $20K
First sale: Feb 2023
Incorporated: Corporation, Delaware, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Panome Bio went on to found or lead other companies.

David SmollerDirectorFounded Solis Agrosciences Edward WeinsteinExecutive Officer, DirectorFounded Canopy Biosciences

Competitors · 2

by search overlap

Oup36 shared keywordsOxford University Press (OUP) provides dictionary data, language datasets, and lexical content in over 60 languages to power digital literacy tools, educational software, gaming platforms, and media experiences. The company works across reading apps, word games, quiz shows, and broadcast media to expand access to language learning and comprehension.

Metabolon27 shared keywordsMetabolon provides metabolomics services and bioinformatics tools that measure small molecules to give biological context to research data. It serves biopharma, public health, consumer wellness, agriculture, and academic research clients across discovery, clinical, and translational studies.

Companies competing with Panome Bio for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Newly launched St. Louis startup Panome Bio raises $6M, plans to double team - St. Louis Business Journalbizjournals.com · Mar 2023

Metabolomics Research Services Firm Panome Bio Raises $6M | GenomeWebgenomeweb.com · Mar 2023

Panome Bio Raises Growth Capital From Telegraph Hill Partners To Expand Next-Generation Metabolomics & Proteomics Businessprnewswire.com · Mar 2023

Panome Bio Raises Growth Fundingfinsmes.com · Mar 2023

Frequently asked questions

What does Panome Bio do?: Panome Bio provides metabolomics, proteomics, and multi-omics integration workflows along with a computational platform that analyzes and integrates diverse biological data types. It serves life science and biotechnology researchers looking to identify biomarkers and generate research insights.
Who founded Panome Bio?: Panome Bio was founded by Edward Weinstein, Tom Cohen in 2022.
Who are Panome Bio's investors?: Panome Bio's investors include BioGenerator Ventures, Telegraph Hill Partners, Cultivation Capital.
How much funding has Panome Bio raised?: Panome Bio has disclosed $12M raised across 2 rounds.
Where is Panome Bio headquartered?: Panome Bio is headquartered in Saint Louis, US.